MSB 1.90% $1.03 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-73

  1. 5,473 Posts.
    lightbulb Created with Sketch. 8901
    Absolutely best possible outcome , adult trial is likely to get the green light too… resubmission and AA for LVAD… very interesting end of 2024 and start of 2025
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.020(1.90%)
Mkt cap ! $1.176B
Open High Low Value Volume
$1.06 $1.06 $1.02 $4.273M 4.146M

Buyers (Bids)

No. Vol. Price($)
11 106344 $1.03
 

Sellers (Offers)

Price($) Vol. No.
$1.03 117234 19
View Market Depth
Last trade - 14.29pm 16/05/2024 (20 minute delay) ?
Last
$1.03
  Change
-0.020 ( 2.94 %)
Open High Low Volume
$1.06 $1.06 $1.02 667604
Last updated 14.48pm 16/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.